Article info
Original research
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission
- Correspondence to Dr Oren Smaletz, Oncology Department, Hospital Israelita Albert Einstein, Sao Paulo 05651-901, Brazil; oren.smaletz{at}einstein.br
Citation
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission
Publication history
- Received November 10, 2020
- Revision received February 18, 2021
- Accepted February 19, 2021
- First published March 4, 2021.
Online issue publication
January 08, 2022
Article Versions
- Previous version (1 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.